ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

NCI Research Grant Funding To Exceed $1.5 Billion, Support 4,800 Grants, In FY00.

January 14, 2000

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

ASCO Releases Guideline On Use Of Growth Factors

May 26, 2006

Pregnancy-Associated Breast Cancer More Likely Diagnosed At Advanced Stage

February 27, 2009